Preserving pregnancy during wartime and demographic crisis in Ukraine: scientific evidence and clinical expertise in progestogen application

Resolution of the International expert meeting

Authors

DOI:

https://doi.org/10.18370/2309-4117.2025.77.78

Abstract

Вважаємо за необхідне виступити з пропозицією запровадити в Україні єдиний міждисциплінарний підхід до надання медичної допомоги пацієнткам з невиношуванням вагітності та передчасними пологами, спираючись на результати аналізу завершених багатоцентрових рандомізованих контрольованих досліджень останніх років [1] і рекомендації чинних настанов профільних професійних асоціацій країн ЄС, Великої Британії, Австралії та США [2–10], а також, зважаючи на критичну демографічну ситуацію, що склалася в нашій країні [11].

References

  1. Coomarasamy A, Devall AJ, Brosens JJ, et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020 Aug;223(2):167–176. DOI: 10.1016/j.ajog.2019.12.006
  2. National Institute for Health and Care Excellence (NICE). Ectopic pregnancy and miscarriage: diagnosis and initial management [NG126]. Updated 24 November 2021. Available from: https://www.nice.org.uk/guidance/ng126
  3. Queensland Health. Queensland Clinical Guideline: Early pregnancy loss. Brisbane: Queensland Government; October 2022. MN22.29-V6-R27. Available from: https://www.health.qld.gov.au
  4. ESHRE Guideline Group on RPL. 2023 ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2023 Mar 2;2023(1):hoad002. Available from: http://dx.doi.org/10.1093/hropen/hoad002
  5. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). S2k-Leitlinie: Diagnostik und Therapie von Frauen mit wiederholten Spontanaborten, Langfassung, Version 6.1. August 2022. AWMF-Leitlinien-Register Nr. 015-050. Available from: https://www.awmf.org/leitlinien/detail/ll/015-050.html
  6. Regan L, Rai R, Saravelos S, et al. Recurrent Miscarriage: Green-top Guideline No. 17. BJOG. 2023 Nov;130(12):e9–e39. DOI: 10.1111/1471-0528.17515
  7. Journal of Obstetrics and Gynaecology Canada (JOGC). Guideline No. 398: Progesterone for the prevention of spontaneous preterm birth. J Obstet Gynaecol Can. 2020;42(6):806–812. DOI: 10.1016/j.jogc.2019.04.012
  8. Salomon LJ, Alfirevic Z, Da Silva Costa F, et al. ISUOG Practice Guidelines: role of ultrasound in the prediction of spontaneous preterm birth. Ultrasound Obstet Gynecol. 2022;59(3):312–324. DOI: 10.1002/uog.26020
  9. National Institute for Health and Care Excellence (NICE). Preterm labour and birth [NG25]. Updated 2023. Available from: https://www.nice.org.uk/guidance/ng25
  10. Dhillon-Smith RK, Melo P, Kaur R, et al. Interventions to prevent miscarriage. Fertil Steril. 2023 Nov;120(5):951-954. DOI: 10.1016/j.fertnstert.2023.08.955
  11. United Nations (2025). World Fertility Report 2024. UN DESA/POP/2024/TR/NO.10. New York: United Nations. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/undesa_pd_2025_wfr_2024_final.pdf
  12. Devall AJ, Papadopoulou A, Podesek M, et al. Progestogens for preventing miscarriage: a network metaanalysis. Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No.: CD013792. DOI: 10.1002/14651858.cd013792.pub2
  13. EPPPIC Group. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomized controlled trials. Lancet 2021. DOI: 10.1016/s0140-6736(21)00217-8
  14. Care A, Nevitt S J, Medley N, et al. Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis BMJ 2022; 376:e064547. DOI: 10.1136/bmj-2021-064547
  15. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryotic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73(2): 300–304. Available from: https://doi.org/10.1016/s0015-0282(99)00495-1
  16. Coomarasamy A, Williams H, Truchanowicz E, et al. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomized, double-blind, placebo-controlled, international multicenter trial and economic evaluation. Health Technol Assess 2016;20(41). DOI: 10.3310/hta20410
  17. Chester, M.R., Tirlapur, A. and Jayaprakasan, K. Current management of recurrent pregnancy loss. Obstet Gynecol. 2022;24: 260-271. Available from: https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1111/tog.12832
  18. Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, et al. Recurrent miscarriage: evidence to accelerate action. Lancet. 2021 May 1;397(10285):1675–1682. DOI: 10.1016/s0140-6736(21)00681-4
  19. Coomarasamy A, Williams H, Truchanowicz E, et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med 2015; 373:2141-2148. DOI: 10.1056/nejmoa1504927
  20. Coomarasamy A, Devall AJ, Cheed V, et al. A Randomized trial of progesterone in women with bleeding in early pregnancy. N Engl J Med 2019; 380:1815-24. DOI: 10.1056/nejmoa1813730
  21. Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration’s withdrawal of 17-alpha hydroxyprogesterone caproate. Am J Obstet Gynecol. 2023 Jul;229(1):B2–B6. DOI: 10.1016/j.ajog.2023.04.012

Downloads

Published

2025-05-30

How to Cite

Editor, E. (2025). Preserving pregnancy during wartime and demographic crisis in Ukraine: scientific evidence and clinical expertise in progestogen application: Resolution of the International expert meeting. REPRODUCTIVE ENDOCRINOLOGY, (77), 78. https://doi.org/10.18370/2309-4117.2025.77.78

Issue

No. 77 (2025)

Section

Events

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.